Page 6 - External Communications News Today

EQS-News: KWS SAAT SE & Co. KGaA / Key word: Miscellaneous KWS mourns the loss of Philip Freiherr von dem Bussche 10.04.2024 / 14:50 CET/CEST The issuer is solely...

As part of Christian Vinther Christensen, COO, Freight Services & Trading , deciding to step down, NORDEN today announces an internal reorganisation, which further strengthens the companys...

MONTREAL, April 08, 2024 -- Boralex inc. announces that the release of the 2024 first quarter results will take place on Wednesday, May 15, 2024, at 9 a.m. Financial analysts and investors are...

BP America has asked iHeartMedia to not place ads on podcasts that use ad revenue to fund political contributions. The announcement follows revelations that the radio giant funneled hundreds of thousands of dollars in ad revenue from Texas Republican Sen. Ted Cruz’s “Verdict” podcast to a pro-Cruz super PAC, Truth and Courage PAC. iHeart Media […]

Alabama is blessed with many natural wonders and diverse ecosystems that provide abundant opportunities for Alabamians and visitors alike to enjoy. A group of folks in south Alabama wants to

MIAMI & DALLAS, April 05, 2024--Southern Glazer's Wine & Spirits (Southern Glazer's)—the world’s preeminent distributor of beverage alcohol—today announced that it has promoted John Landry to the role of Executive Vice President, General Manager, California, effective immediately. Until a successor is named, Landry will continue to oversee the Nevada market to ensure a smooth transition.

Numerous studies conducted by researchers at Dana-Farber Cancer Institute show promising results for patients with endometrial, lung, breast, prostate, and colo

BP America has asked iHeartMedia to not place ads on podcasts that use ad revenue to fund political contributions. The announcement follows revelations that the radio giant funneled hundreds of thousands of dollars in ad revenue from Texas Republican Sen. Ted Cruz’s “Verdict” podcast to a pro-Cruz super PAC, Truth and Courage PAC. iHeart Media…

Numerous studies conducted by researchers at Dana-Farber Cancer Institute show promising results for patients with endometrial, lung, breast, prostate, and colo

In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune